infliximab

Details

Instance of

type of chemical entity

Subclass of

chemical compound

active ingredient in

Flixabi, Inflectra, Remicade, Remsima

defined daily dose

3.75

has characteristic

biopharmaceutical

has use

medication

legal status (medicine)

boxed warning

LiverTox likelihood score

LiverTox toxicity likelihood category A

medical condition treated

polyarthritis, pyoderma gangrenosum, colitis, ankylosing spondylitis, Takayasu's arteritis, arthritis, ulcerative colitis, Behçet's disease, uveitis, Kawasaki disease, irritable bowel syndrome, spondylitis

pregnancy category

Australian pregnancy category C, US pregnancy category B

route of administration

intravenous infusion and defusion

stylized name

inFLIXimab

subject has role

immunologic factor, disease-modifying antirheumatic drug, dermatologic drug, gastrointestinal agent, monoclonal antibody

World Health Organisation international non-proprietary name

infliximab, infliximabum, infliximab, infliximab, инфликсимаб, إينفليكسيماب, 英利昔单抗

Authority files